|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-12-17
|
|
pubmed:abstractText |
Accumulating evidence suggests that alpha7 nicotinic receptor (alpha7 nAChR) agonists could be potential therapeutic drugs for cognitive deficits in schizophrenia. The present study was undertaken to examine the effects of the novel selective alpha7 nAChR agonist SSR180711 on cognitive deficits in mice after repeated administration of the N-methyl-D-aspartate receptor antagonist phencyclidine (PCP).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1873-2402
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
63
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
92-7
|
|
pubmed:dateRevised |
2008-4-2
|
|
pubmed:meshHeading |
pubmed-meshheading:17601496-Aconitine,
pubmed-meshheading:17601496-Analysis of Variance,
pubmed-meshheading:17601496-Animals,
pubmed-meshheading:17601496-Behavior, Animal,
pubmed-meshheading:17601496-Bicyclo Compounds, Heterocyclic,
pubmed-meshheading:17601496-Brain,
pubmed-meshheading:17601496-Cognition Disorders,
pubmed-meshheading:17601496-Drug Administration Schedule,
pubmed-meshheading:17601496-Drug Interactions,
pubmed-meshheading:17601496-Male,
pubmed-meshheading:17601496-Mice,
pubmed-meshheading:17601496-Mice, Inbred ICR,
pubmed-meshheading:17601496-Nicotinic Antagonists,
pubmed-meshheading:17601496-Phencyclidine
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711.
|
|
pubmed:affiliation |
Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan. hashimoto@faculty.chiba-u.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
